These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23383694)

  • 21. Differentiation of endometrial adenocarcinoma from adenocarcinoma of cervix using kinetic parameters derived from DCE-MRI.
    Lin M; Zhang Q; Song Y; Yu X; Ouyang H; Xie L; Shang Y
    Eur J Radiol; 2020 Sep; 130():109190. PubMed ID: 32745897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI.
    Just N; Koh DM; D'Arcy J; Collins DJ; Leach MO
    NMR Biomed; 2011 Aug; 24(7):902-15. PubMed ID: 21290457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats.
    McGrath DM; Bradley DP; Tessier JL; Lacey T; Taylor CJ; Parker GJ
    Magn Reson Med; 2009 May; 61(5):1173-84. PubMed ID: 19253360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
    Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
    Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
    Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission.
    Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT
    Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
    Lee J; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.
    Yamashita Y; Baba T; Baba Y; Nishimura R; Ikeda S; Takahashi M; Ohtake H; Okamura H
    Radiology; 2000 Sep; 216(3):803-9. PubMed ID: 10966715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation.
    Gaens ME; Backes WH; Rozel S; Lipperts M; Sanders SN; Jaspers K; Cleutjens JP; Sluimer JC; Heeneman S; Daemen MJ; Welten RJ; Daemen JW; Wildberger JE; Kwee RM; Kooi ME
    Radiology; 2013 Jan; 266(1):271-9. PubMed ID: 23151823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters.
    Wang H; Su Z; Ye H; Xu X; Sun Z; Li L; Duan F; Song Y; Lambrou T; Ma L
    Medicine (Baltimore); 2015 Sep; 94(37):e1529. PubMed ID: 26376399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments.
    He D; Zamora M; Oto A; Karczmar GS; Fan X
    Phys Med Biol; 2017 Sep; 62(18):N445-N459. PubMed ID: 28786402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operator dependency of arterial input function in dynamic contrast-enhanced MRI.
    Kleppestø M; Bjørnerud A; Groote IR; Kim M; Vardal J; Larsson C
    MAGMA; 2022 Feb; 35(1):105-112. PubMed ID: 34213687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.